Literature DB >> 3760068

Comparison of gas chromatography and high-performance liquid chromatography for the analysis of probucol in plasma.

D K Satonin, J E Coutant.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3760068     DOI: 10.1016/s0378-4347(00)83670-1

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  6 in total

1.  Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits.

Authors:  A Daugherty; B S Zweifel; G Schonfeld
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

2.  Antiatherosclerotic effect of probucol in WHHL rabbits: are there plasma parameters to evaluate this effect?

Authors:  B Finckh; A Niendorf; M Rath; U Beisiegel
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Identification and characterization of small-molecule inhibitors of hepsin.

Authors:  John R Chevillet; Gemma J Park; Antonio Bedalov; Julian A Simon; Valeri I Vasioukhin
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

Review 4.  Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.

Authors:  M M Buckley; K L Goa; A H Price; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

5.  Ischemic acute renal failure and antioxidant therapy in the rat. The relation between glomerular and tubular dysfunction.

Authors:  J E Bird; K Milhoan; C B Wilson; S G Young; C A Mundy; S Parthasarathy; R C Blantz
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits.

Authors:  Yanli Wang; Liang Bai; Yan Lin; Yulong Chen; Hua Guan; Ninghong Zhu; Yafeng Li; Shoucui Gao; Lijing Sun; Sihai Zhao; Jianglin Fan; Enqi Liu
Journal:  Lipids Health Dis       Date:  2015-07-29       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.